Your browser doesn't support javascript.
loading
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.
Lewis, Elizabeth C; Kraveka, Jacqueline M; Ferguson, William; Eslin, Don; Brown, Valerie I; Bergendahl, Genevieve; Roberts, William; Wada, Randal K; Oesterheld, Javier; Mitchell, Deanna; Foley, Jessica; Zage, Peter; Rawwas, Jawhar; Rich, Maria; Lorenzi, Elizabeth; Broglio, Kristine; Berry, Donald; Saulnier Sholler, Giselle L.
Afiliação
  • Lewis EC; Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, USA.
  • Kraveka JM; Medical University of South Carolina, Charleston, South Carolina, USA.
  • Ferguson W; St. Louis University School of Medicine, St. Louis, Missouri, USA.
  • Eslin D; Arnold Palmer Hospital for Children, Orlando, Florida, USA.
  • Brown VI; Penn State Health Children's Hospital at the Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
  • Bergendahl G; Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, USA.
  • Roberts W; Rady Children's Hospital-San Diego and UC San Diego School of Medicine, San Diego, California, USA.
  • Wada RK; Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, USA.
  • Oesterheld J; Levine Children's Hospital, Charlotte, North Carolina, USA.
  • Mitchell D; Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, USA.
  • Foley J; Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA.
  • Zage P; Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, USA.
  • Rawwas J; Rady Children's Hospital-San Diego and UC San Diego School of Medicine, San Diego, California, USA.
  • Rich M; Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, USA.
  • Lorenzi E; Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, USA.
  • Broglio K; Berry Consultants, LLC, Austin, Texas, USA.
  • Berry D; Berry Consultants, LLC, Austin, Texas, USA.
  • Saulnier Sholler GL; Berry Consultants, LLC, Austin, Texas, USA.
Int J Cancer ; 147(11): 3152-3159, 2020 12 01.
Article em En | MEDLINE | ID: mdl-32391579
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eflornitina / Neuroblastoma Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eflornitina / Neuroblastoma Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article